SCHEMBL5016641

SCHEMBL5016641

c1ccc2c(c1)Cc1cc3c(cc1-2)Cc1cc2c(cc1-3)Cc1ccccc1-2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.64
NPC1 O15118 3/20 0.64
MAPT P10636 3/20 0.64
RAB9A P51151 3/20 0.64
ALDH1A1 P00352 2/20 0.64
KDM4E B2RXH2 2/20 0.64
HPGD P15428 2/20 0.64
LMNA P02545 1/20 0.64
MAOA P21397 2/20 0.56
SRD5A2 P31213 1/20 0.55
CYP1A2 P05177 4/20 0.52
CYP3A4 P08684 4/20 0.52
HTR2C P28335 2/20 0.48
HTR2B P41595 2/20 0.48
ADRA2A P08913 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
PGR P06401 2/20 0.47
BCHE P06276 1/20 0.46
CES1 P23141 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18582934 1.00 SMN1; SMN2 (0.64) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL30912172 1.00 SMN1; SMN2 (0.64) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL5058433 1.00 SMN1; SMN2 (0.64) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL29924230 0.92 SMN1; SMN2 (0.61) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL3280539 0.92 SMN1; SMN2 (0.61) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL5357317 0.91 RAB9A (0.55) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL2720506 0.88 ALDH1A1 (0.70) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
Fluorene SCHEMBL8180 0.88 MAOA (0.68) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
Fluorene SCHEMBL31388525 0.88 MAOA (0.68) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
Fluorene SCHEMBL29478468 0.88 MAOA (0.68) SMN1; SMN2NPC1MAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9461249-B2 Compounds for organic electronic devices MERCK PATENT GMBH (DE) 2016-10-04 US disclosed
US-20150031896-A1 COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-01-29 US disclosed
US-8852756-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-10-07 US disclosed
US-20080220285-A1 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices MERCK PATENT GMBH (DE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080220285-A1 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices TYR, DDT, PAH SMN1; SMN2 1453/4885NPC1 1783/4885MAPT 915/4885
US-20150031896-A1 COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES TYR, TOE1, GPX1 SMN1; SMN2 2671/4885NPC1 2095/4885MAPT 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.